FDA Clearance Tracker · K243289
ADDNOX (BPSPM1)
Last checked: Nov 19, 2026Latest source record: Jan 16, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jan 16, 2025
Substantially Equivalent
Time to decision
90 days
Received Oct 18, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K243289
- Device name
- ADDNOX (BPSPM1)
- Applicant
- Nu Eyne Co., Ltd.
- Applicant location
- Seoul, KR
- Received
- Oct 18, 2024
- Decided
- Jan 16, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5898
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QGL. The earliest in FDA's data is DEN180041, decided Apr 19, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243289
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Nu Eyne Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- ELEXIR 2.0 (ALLIVE3)510(k)
K242719 · Decided Nov 6, 2024 · 57 days after receipt
Device type: Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (PCC) · Neurology & Neurosurgery
- SMILE510(k)
K213629 · Decided Feb 12, 2023 · 452 days after receipt
Device type: Transcutaneous Nerve Stimulator For Adhd (QGL) · Neurology & Neurosurgery
- Elexir510(k)
K211380 · Decided Jul 30, 2021 · 87 days after receipt
Device type: Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (PCC) · Neurology & Neurosurgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.